BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8923595)

  • 1. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raising awareness of Raynaud's phenomenon and scleroderma.
    Mawdsley AH; Brown SJ
    Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis.
    Pauling JD; Shipley JA; Harris ND; McHugh NJ
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S103-15. PubMed ID: 22691218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential diagnosis of Raynaud's phenomenon.
    Wigley FM
    Hosp Pract (Off Ed); 1991 Jul; 26(7):63-70, 73-84. PubMed ID: 2071684
    [No Abstract]   [Full Text] [Related]  

  • 6. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Clements PJ
    Curr Opin Rheumatol; 1994 Nov; 6(6):603-6. PubMed ID: 7865380
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Cutolo M
    Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. French translation and linguistic validation of the Raynaud's condition score.
    Khouri C; Blaise S; Guigui A; Cracowski C; Allanore Y; Hachulla E; Senet P; Roustit M; Cracowski JL
    Therapie; 2019 Dec; 74(6):627-631. PubMed ID: 31023622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon and vascular disease in scleroderma.
    Kahaleh MB
    Curr Opin Rheumatol; 1994 Nov; 6(6):621-7. PubMed ID: 7865384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon.
    Herrick AL; Wigley FM
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon. An update.
    Coffman JD
    Hypertension; 1991 May; 17(5):593-602. PubMed ID: 2022404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.